Annual Book Value
$428.68 M
+$186.32 M+76.88%
December 31, 2024
Summary
- As of March 1, 2025, TRDA annual book value is $428.68 million, with the most recent change of +$186.32 million (+76.88%) on December 31, 2024.
- During the last 3 years, TRDA annual book value has risen by +$129.96 million (+43.51%).
- TRDA annual book value is now at all-time high.
Performance
TRDA Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$428.68 M
+$6.23 M+1.47%
December 31, 2024
Summary
- As of March 1, 2025, TRDA quarterly book value is $428.68 million, with the most recent change of +$6.23 million (+1.47%) on December 31, 2024.
- Over the past year, TRDA quarterly book value has dropped by -$1.25 million (-0.29%).
- TRDA quarterly book value is now -0.29% below its all-time high of $429.93 million, reached on June 30, 2024.
Performance
TRDA Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
TRDA Book Value Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +76.9% | -0.3% |
3 y3 years | +43.5% | +101.7% |
5 y5 years | +2862.5% | +101.7% |
TRDA Book Value Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +101.7% | -0.3% | +107.2% |
5 y | 5-year | at high | +1133.2% | -0.3% | +690.5% |
alltime | all time | at high | +1133.2% | -0.3% | +690.5% |
Entrada Therapeutics Book Value History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $428.68 M(+76.9%) | $428.68 M(+1.5%) |
Sep 2024 | - | $422.45 M(-1.7%) |
Jun 2024 | - | $429.93 M(+59.6%) |
Mar 2024 | - | $269.37 M(+11.1%) |
Dec 2023 | $242.36 M(+14.0%) | $242.36 M(-1.7%) |
Sep 2023 | - | $246.66 M(+19.2%) |
Jun 2023 | - | $206.91 M(-9.9%) |
Mar 2023 | - | $229.61 M(+8.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $212.55 M(-28.8%) | $212.55 M(-8.9%) |
Sep 2022 | - | $233.22 M(-8.9%) |
Jun 2022 | - | $256.04 M(-7.7%) |
Mar 2022 | - | $277.39 M(-7.1%) |
Dec 2021 | $298.72 M(-820.0%) | $298.72 M(-511.5%) |
Sep 2021 | - | -$72.59 M(+23.0%) |
Jun 2021 | - | -$59.01 M(+42.2%) |
Dec 2020 | -$41.49 M(+167.4%) | -$41.49 M |
Dec 2019 | -$15.52 M | - |
FAQ
- What is Entrada Therapeutics annual book value?
- What is the all time high annual book value for Entrada Therapeutics?
- What is Entrada Therapeutics annual book value year-on-year change?
- What is Entrada Therapeutics quarterly book value?
- What is the all time high quarterly book value for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly book value year-on-year change?
What is Entrada Therapeutics annual book value?
The current annual book value of TRDA is $428.68 M
What is the all time high annual book value for Entrada Therapeutics?
Entrada Therapeutics all-time high annual book value is $428.68 M
What is Entrada Therapeutics annual book value year-on-year change?
Over the past year, TRDA annual book value has changed by +$186.32 M (+76.88%)
What is Entrada Therapeutics quarterly book value?
The current quarterly book value of TRDA is $428.68 M
What is the all time high quarterly book value for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly book value is $429.93 M
What is Entrada Therapeutics quarterly book value year-on-year change?
Over the past year, TRDA quarterly book value has changed by -$1.25 M (-0.29%)